Teva Pharma (TEVA) Launches Generic Gleevec Tablets in U.S.
Tweet Send to a Friend
Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of the generic equivalent to Gleevec®1(imatinib mesylate) tablets,100 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE